Tencent-backed healthcare firm WeDoctor Group, Hong Kong-listed financial services company Mason Group and Asian investment firm Aldworth Management will reportedly team up to acquire Australian fertility treatment firm Genea for an estimated HKD4 billion (about US$509 million), according to media reports.
Hong Kong-Based Consortium Reportedly To Buy Australian Fertility Treatment Provider For US$509M appeared first on China Money Network.